These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19099628)

  • 21. [Mechanism of G2/M blockage triggered by activated-Chk1 in regulation of drug-resistance in K562/A02 cell line].
    Wang HY; Zhang M; Zou P; You Y; Guo JM; Tang XQ; Zhao ZG; Wu YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1105-9. PubMed ID: 17204173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of hypoxia inducible factor1-α inhibitor on reversal of multidrug resistance of K562/A02 cell line].
    Chen BA; Wang F; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Xia GH; Shan XY
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):389-93. PubMed ID: 21122354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
    Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
    Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells.
    Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM
    Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal effects of hyaluronan oligosaccharides on adriamycin resistance of K562/A02 cells.
    Cui X; Zhou S; Xu H; Zhao T; Liu A; Guo X; Wang F
    Anticancer Drugs; 2009 Oct; 20(9):800-6. PubMed ID: 19606017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Mechanism of Bufalin-Induced Apoptosis of K562/A02.
    Xie Y; Yan X; Sun L
    Med Sci Monit; 2019 Apr; 25():2542-2552. PubMed ID: 30955024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profile of Notch-related genes in multidrug resistant K562/A02 cells compared with parental K562 cells.
    Yan S; Ma D; Ji M; Guo D; Dai J; Zhao P; Ji C
    Int J Lab Hematol; 2010 Apr; 32(2):150-8. PubMed ID: 19302234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms.
    Zhao D; Jiang Y; Dong X; Liu Z; Qu B; Zhang Y; Ma N; Han Q
    Biomed Pharmacother; 2011 Aug; 65(5):354-8. PubMed ID: 21775093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Screening for drug resistance related microRNAs in K562 and K562/A02 cell lines].
    Cao YX; Dai CW; Zhang GS
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):361-5. PubMed ID: 21122348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Apoptosis of the adriamycin-resistant leukemia cell line induced by the recombinant mutant human TNF-related apoptosis-inducing ligand combined with arsenic trioxide].
    Wang YR; Wen SP; Wang FX; Wen L; Yang BY; Yang JC; Zhang XJ; Yang SF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1055-9. PubMed ID: 18928594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance.
    Li RJ; Zhang GS; Chen YH; Zhu JF; Lu QJ; Gong FJ; Kuang WY
    Ann Oncol; 2010 Jul; 21(7):1506-1514. PubMed ID: 20038517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line].
    Li J; Chen BA; Zhu MS; Gao F; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Song HH; Ma Y; Bao W; Sun XC; Cheng HY; Xu WL; Shen HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):65-9. PubMed ID: 18315902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Identification of differentially expressed genes involved in multidrug resistance in K562/A02 by cDNA microarray].
    Tan YH; Yang CZ; Zhao CH; Qi J; Peng H; Wang JX; Zhou Y; Xiao Y; Lan L
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):328-32. PubMed ID: 15312340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDR reversal activity of bromotetrandrine in vitro and in vivo.
    Cheng J; Wang JQ; Chen BA; Gao F; Xu WL; Shen HL; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Song HH; Bao W; Sun Q; Dai YY; Sun XC; Cheng HY; Deng YX; Li GH; Chen NN; Liu LJ; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1183-91. PubMed ID: 19840447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the compound Fritilaria thunbergii Miq particles to the subcellular accumulation ability and inducing apoptosis of K562/A02 cells].
    Zheng Z; Li DY; Chen XY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):167-9. PubMed ID: 20462045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
    Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Role and Mechanism of MiR-451 in Multidrug Resistance of Leukemia Cell Line K562/A02].
    Feng YL; Su BX; Ge FM; Dai CW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):685-692. PubMed ID: 37356927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [VEGF shRNA enhances the sensitivity of multidrug-resistant leukemia cells to anticancer agent].
    Shen HL; Fang LL; Chen C; Fang XJ; Chen QY; Li J; Xu WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):34-9. PubMed ID: 21362217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of WAVE1 in drug resistance of K562/A02 leukemia cells].
    Kang R; Cao LZ; Yu Y; Hu T; Wang Z; Xu WQ; Xie M
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):379-82. PubMed ID: 17939402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
    Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
    Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.